- Datum24.02.2025
- Uhrzeit08:00 - 09:00 Uhr
- Veranstalter
XTB
Kein Moderator verfügbar
SIGA Technologies Inc. Aktie
Verkaufen
Kaufen
SIGA Technologies Inc. Chart
SIGA Technologies Inc. Realtime-Kurs
| Name | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| Nasdaq | VK | |||||
| Nasdaq Basic | VK | |||||
| Cboe BZX | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (Nasdaq)
-3,59 %
Intraday
-3,83 %
1 Woche
-8,73 %
1 Monat
-1,75 %
Seit Jahresbeginn
11,00 %
1 Jahr
-1,42 %
3 Jahre
24,84 %
5 Jahre
189,46 %
10 Jahre
Wikifolio
Passender Service zu SIGA Technologies Inc.
Webinar zu SIGA Technologies Inc.
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)4,750-12,830
- Jahrestief / Hoch ($)5,640-6,610
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von SIGA Technologies Inc.
| Ex-Datum | Fiskaljahr | Dividende | Rendite |
|---|---|---|---|
| 16.05.2022 | - | 0,45 $ | 6,03 % |
| 15.05.2023 | - | 0,45 $ | 7,61 % |
| 25.03.2024 | - | 0,60 $ | 6,85 % |
Termine von SIGA Technologies Inc.
- Feb27SIGA Technologies Inc.Q4 2024 Earnings Release
- Mai1SIGA Technologies Inc.Q1 2025 Earnings Release
- Jul31SIGA Technologies Inc.Q2 2025 Earnings Release
Beschreibung
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.
